Krishna Institute of Medical Sciences Limited

NSEI:KIMS Stok Raporu

Piyasa değeri: ₹220.0b

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Krishna Institute of Medical Sciences Yönetim

Yönetim kriter kontrolleri 2/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Abhinay Bollineni

İcra Kurulu Başkanı

₹22.0m

Toplam tazminat

CEO maaş yüzdesi77.3%
CEO görev süresi5.3yrs
CEO sahipliği0.07%
Yönetim ortalama görev süresiVeri yok
Yönetim Kurulu ortalama görev süresi2.4yrs

Son yönetim güncellemeleri

We Think The Compensation For Krishna Institute of Medical Sciences Limited's (NSE:KIMS) CEO Looks About Right

Aug 23
We Think The Compensation For Krishna Institute of Medical Sciences Limited's (NSE:KIMS) CEO Looks About Right

Recent updates

There's Reason For Concern Over Krishna Institute of Medical Sciences Limited's (NSE:KIMS) Massive 26% Price Jump

Sep 05
There's Reason For Concern Over Krishna Institute of Medical Sciences Limited's (NSE:KIMS) Massive 26% Price Jump

We Think The Compensation For Krishna Institute of Medical Sciences Limited's (NSE:KIMS) CEO Looks About Right

Aug 23
We Think The Compensation For Krishna Institute of Medical Sciences Limited's (NSE:KIMS) CEO Looks About Right

Krishna Institute of Medical Sciences Limited (NSE:KIMS) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Aug 10
Krishna Institute of Medical Sciences Limited (NSE:KIMS) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Is Krishna Institute of Medical Sciences (NSE:KIMS) Using Too Much Debt?

Jul 02
Is Krishna Institute of Medical Sciences (NSE:KIMS) Using Too Much Debt?

Krishna Institute of Medical Sciences Limited's (NSE:KIMS) Shares May Have Run Too Fast Too Soon

Jun 12
Krishna Institute of Medical Sciences Limited's (NSE:KIMS) Shares May Have Run Too Fast Too Soon

Is Now The Time To Put Krishna Institute of Medical Sciences (NSE:KIMS) On Your Watchlist?

Apr 28
Is Now The Time To Put Krishna Institute of Medical Sciences (NSE:KIMS) On Your Watchlist?

We Like These Underlying Return On Capital Trends At Krishna Institute of Medical Sciences (NSE:KIMS)

Apr 10
We Like These Underlying Return On Capital Trends At Krishna Institute of Medical Sciences (NSE:KIMS)

Risks To Shareholder Returns Are Elevated At These Prices For Krishna Institute of Medical Sciences Limited (NSE:KIMS)

Feb 29
Risks To Shareholder Returns Are Elevated At These Prices For Krishna Institute of Medical Sciences Limited (NSE:KIMS)

Krishna Institute of Medical Sciences Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Feb 08
Krishna Institute of Medical Sciences Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Krishna Institute of Medical Sciences Limited (NSE:KIMS) Shares Could Be 34% Above Their Intrinsic Value Estimate

Jan 23
Krishna Institute of Medical Sciences Limited (NSE:KIMS) Shares Could Be 34% Above Their Intrinsic Value Estimate

Investors Will Want Krishna Institute of Medical Sciences' (NSE:KIMS) Growth In ROCE To Persist

Nov 21
Investors Will Want Krishna Institute of Medical Sciences' (NSE:KIMS) Growth In ROCE To Persist

Do Krishna Institute of Medical Sciences' (NSE:KIMS) Earnings Warrant Your Attention?

Aug 23
Do Krishna Institute of Medical Sciences' (NSE:KIMS) Earnings Warrant Your Attention?

Returns Are Gaining Momentum At Krishna Institute of Medical Sciences (NSE:KIMS)

Aug 02
Returns Are Gaining Momentum At Krishna Institute of Medical Sciences (NSE:KIMS)

Krishna Institute of Medical Sciences' (NSE:KIMS) Returns On Capital Are Heading Higher

Apr 01
Krishna Institute of Medical Sciences' (NSE:KIMS) Returns On Capital Are Heading Higher

Krishna Institute of Medical Sciences (NSE:KIMS) Is Looking To Continue Growing Its Returns On Capital

Dec 14
Krishna Institute of Medical Sciences (NSE:KIMS) Is Looking To Continue Growing Its Returns On Capital

Analysts Have Made A Financial Statement On Krishna Institute of Medical Sciences Limited's (NSE:KIMS) First-Quarter Report

Aug 13
Analysts Have Made A Financial Statement On Krishna Institute of Medical Sciences Limited's (NSE:KIMS) First-Quarter Report

Krishna Institute of Medical Sciences (NSE:KIMS) Is Investing Its Capital With Increasing Efficiency

Aug 12
Krishna Institute of Medical Sciences (NSE:KIMS) Is Investing Its Capital With Increasing Efficiency

Here's Why Krishna Institute of Medical Sciences (NSE:KIMS) Has Caught The Eye Of Investors

Jul 02
Here's Why Krishna Institute of Medical Sciences (NSE:KIMS) Has Caught The Eye Of Investors

Krishna Institute of Medical Sciences Limited (NSE:KIMS) Investors Are Less Pessimistic Than Expected

May 08
Krishna Institute of Medical Sciences Limited (NSE:KIMS) Investors Are Less Pessimistic Than Expected

CEO Tazminat Analizi

Abhinay Bollineni'un ücretlendirmesi Krishna Institute of Medical Sciences'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

₹3b

Mar 31 2024₹22m₹17m

₹3b

Dec 31 2023n/an/a

₹3b

Sep 30 2023n/an/a

₹3b

Jun 30 2023n/an/a

₹3b

Mar 31 2023₹20m₹15m

₹3b

Dec 31 2022n/an/a

₹3b

Sep 30 2022n/an/a

₹3b

Jun 30 2022n/an/a

₹3b

Mar 31 2022₹12m₹12m

₹3b

Dec 31 2021n/an/a

₹3b

Sep 30 2021n/an/a

₹3b

Jun 30 2021n/an/a

₹3b

Mar 31 2021₹9m₹9m

₹2b

Dec 31 2020n/an/a

₹2b

Mar 31 2020₹8m₹8m

₹1b

Mar 31 2019₹5m₹5m

-₹477m

Tazminat ve Piyasa: Abhinay 'nin toplam tazminatı ($USD 261.98K ), Indian pazarındaki benzer büyüklükteki şirketler için ortalamanın altındadır ($USD 591.73K ).

Tazminat ve Kazançlar: Abhinay 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.


CEO

Abhinay Bollineni (36 yo)

5.3yrs

Görev süresi

₹22,000,000

Tazminat

Dr. Abhinay Bollineni serves as Chief Executive Officer of Krishna Institute of Medical Sciences Limited since July 3, 2019 and has been its Executive Director since January 18, 2019. He holds a bachelor’s...


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Bhaskara Bollineni
Founderno data₹38.67m32.25%
₹ 71.0b
Abhinay Bollineni
CEO & Executive Director5.8yrs₹22.00m0.069%
₹ 151.6m
Anitha Dandamudi
Director of Operations & Wholetime Directorno data₹5.80mVeri yok
Saumen Chakraborty
Independent Directorno data₹3.52mVeri yok
Yalamanchili Rani
Additional Non-Executive & Independent Director2.4yrs₹1.06mVeri yok
Venkata Jasthi
Independent Directorno data₹1.06mVeri yok
Adwik Bollineni
Additional Non-Executive Non-Independent Directorless than a yearVeri yok0.010%
₹ 22.3m
Ratna Kaza
Independent Directorno data₹1.06mVeri yok

2.4yrs

Ortalama Görev Süresi

70yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: KIMS 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilmiyor ( 2.4 yıllık ortalama görev süresi), bu da yeni bir yönetim kurulu olduğunu gösteriyor.